Literature DB >> 30467842

Cancer specific survival in patients with sickle cell disease.

Ann Brunson1, Theresa H M Keegan1, Anjlee Mahajan1, Susan Paulukonis2, Ted Wun1,3.   

Abstract

Sickle cell disease (SCD) patients have a higher incidence of certain cancers, but no studies have determined the impact of cancer on survival among SCD patients. SCD patients (n = 6423), identified from state-wide hospitalisation data, were linked to the California Cancer Registry (1988-2014). Multivariable Cox proportional hazards regression was used to examine survival. Among SCD patients, a cancer diagnosis was associated with a 3-fold increased hazard of death. Compared to matched cancer patients without SCD, SCD was associated with worse overall survival, but not cancer-specific survival, suggesting that SCD cancer patients should be treated with similar therapeutic intent.
© 2018 British Society for Haematology and John Wiley & Sons Ltd.

Entities:  

Keywords:  Sickle cell disease; cancer; epidemiology; survival

Mesh:

Year:  2018        PMID: 30467842      PMCID: PMC8966490          DOI: 10.1111/bjh.15687

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  7 in total

1.  Socioeconomic status and breast cancer incidence in California for different race/ethnic groups.

Authors:  K Yost; C Perkins; R Cohen; C Morris; W Wright
Journal:  Cancer Causes Control       Date:  2001-10       Impact factor: 2.506

2.  Risk of individual malignant neoplasms in patients with sickle cell disease: English national record linkage study.

Authors:  Olena O Seminog; Oyindamola I Ogunlaja; David Yeates; Michael J Goldacre
Journal:  J R Soc Med       Date:  2016-06-20       Impact factor: 5.344

3.  Increased risk of leukemia among sickle cell disease patients in California.

Authors:  Ann Brunson; Theresa H M Keegan; Heejung Bang; Anjlee Mahajan; Susan Paulukonis; Ted Wun
Journal:  Blood       Date:  2017-08-22       Impact factor: 22.113

4.  Osteonecrosis of the femoral head in sickle cell disease: prevalence, comorbidities, and surgical outcomes in California.

Authors:  Oyebimpe Adesina; Ann Brunson; Theresa H M Keegan; Ted Wun
Journal:  Blood Adv       Date:  2017-07-11

5.  Increased incidence of VTE in sickle cell disease patients: risk factors, recurrence and impact on mortality.

Authors:  Ann Brunson; Amy Lei; Aaron S Rosenberg; Richard H White; Theresa Keegan; Ted Wun
Journal:  Br J Haematol       Date:  2017-04-03       Impact factor: 6.998

6.  Pain in sickle cell disease. Rates and risk factors.

Authors:  O S Platt; B D Thorington; D J Brambilla; P F Milner; W F Rosse; E Vichinsky; T R Kinney
Journal:  N Engl J Med       Date:  1991-07-04       Impact factor: 91.245

7.  Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients.

Authors:  Darleen R Powars; Linda S Chan; Alan Hiti; Emily Ramicone; Cage Johnson
Journal:  Medicine (Baltimore)       Date:  2005-11       Impact factor: 1.889

  7 in total
  3 in total

1.  Bleeding in patients with sickle cell disease: a population-based study.

Authors:  Nisha Hariharan; Ann Brunson; Anjlee Mahajan; Theresa H M Keegan; Ted Wun
Journal:  Blood Adv       Date:  2020-03-10

2.  Concurrent use of hydroxyurea and deferasirox in Californians with sickle cell disease.

Authors:  Trisha E Wong; Jhaqueline Valle; Susan Paulukonis
Journal:  Health Sci Rep       Date:  2021-07-14

3.  Treatment and outcomes of hepatocellular carcinoma in patients with Sickle cell disease: a population-based study in the U.S.

Authors:  Arianna Barbetta; Cameron Goldbeck; Angelina Lim; Sean P Martin; Jeffrey A Kahn; M Raashid Sheikh; Juliet Emamaullee
Journal:  HPB (Oxford)       Date:  2021-07-06       Impact factor: 3.842

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.